GSTP1 and osteosarcoma: Furthermore, after the administration of DXR or cisplatin, glutathione-S-transferase P1 (GSTP1) levels were found to be elevated, and amplified GSTP1 expression in SAOS-2 cell lines from osteosarcomas was linked with heightened vulnerability to resistance to these two pharmaceutical reagents (186).